Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature R. J. DamstraH. G. J. VoestenB. van der Lei Review 13 February 2008 Pages: 199 - 206
Ten years of HER2-directed therapy: still questions after all these years Ian E. KropEric P. Winer Invited Commentary 08 May 2008 Pages: 207 - 209
Donor-derived breast cancer in a bone marrow transplantation recipient Vassilis GolfinopoulossGeorge PentheroudakisNicholas Pavlidis Preclinical Study 09 February 2008 Pages: 211 - 213
Donor-derived breast cancer in a bone marrow transplantation recipient Vassilis GolfinopoulosGeorge PentheroudakisNicholas Pavlidis Erratum 29 March 2008 Pages: 215 - 215
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype Monzur RahmanSean R. DavisStanley Lipkowitz Preclinical Study 12 February 2008 Pages: 217 - 230
Integrated gene expression profile predicts prognosis of breast cancer patients Lian-Fang LiXiao-Jing XuZhi-Ming Shao Preclinical Study 16 February 2008 Pages: 231 - 237
Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis Mads ThomassenQihua TanTorben A. Kruse Preclinical Study 22 February 2008 Pages: 239 - 249
Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis Mads ThomassenQihua TanTorben A. Kruse Erratum 09 May 2008 Pages: 251 - 252
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer Danielle MeijerMaurice P. H. M. JansenEls M. J. J. Berns Preclinical Study 26 February 2008 Pages: 253 - 260
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications Rabab A. A. MohammedIan O. EllisStewart G. Martin Preclinical Study 22 February 2008 Pages: 261 - 273
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen Marleen KokSabine C. LinnEls M. J. J. Berns Preclinical Study 04 March 2008 Pages: 275 - 283
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines Marijke WasielewskiPejman Hanifi-MoghaddamMieke Schutte Preclinical Study 24 February 2008 Pages: 285 - 291
Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC) Neal T. HolmFleurette AbreoQuyen D. Chu Clinical Trial 13 February 2008 Pages: 293 - 299
HER-2/neu expression in primary and metastatic breast cancer Elyse E. LowerEleanor GlassStacy Harman Clinical Trial 14 February 2008 Pages: 301 - 306
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome Tadahiko ShienChikako ShimizuYasuhiro Fujiwara Clinical Trial 20 February 2008 Pages: 307 - 313
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial Sandra M. SwainStephanie R. LandPatricia A. Ganz Clinical Trial 27 February 2008 Pages: 315 - 320
Long-term “protective” effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients O. MarkovitchR. TepperI. Cohen Clinical Trial 23 February 2008 Pages: 321 - 326
Racial and ethnic differences in mammography use among U.S. women younger than age 40 Julie M. KappA. Blythe RyersonTrevor D. Thompson Epidemiology 09 February 2008 Pages: 327 - 337
Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer Søren ChristensenRobert ZachariaeHans von der Maase Epidemiology 16 February 2008 Pages: 339 - 355
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA Mary Jo LundKatrina F. TriversJ. William Eley Epidemiology 07 March 2008 Pages: 357 - 370
Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility Ana OsorioAlicia BarrosoJavier Benítez Epidemiology 13 February 2008 Pages: 371 - 376
Germline RAP80 mutations and susceptibility to breast cancer Mohammad Reza AkbariParviz GhadirianSteven A. Narod Epidemiology 28 February 2008 Pages: 377 - 381
Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women Kathleen A. MeeskeJane Sullivan-HalleyLeslie Bernstein Epidemiology 24 February 2008 Pages: 383 - 391
BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer S. Eric MartinMark SausenEric S. Martin Report 02 March 2008 Pages: 393 - 395
The surgical margin status after breast-conserving surgery: discussion of an open issue Alberto LuiniJoel RososchanskyAntonio Frasson Report 04 April 2008 Pages: 397 - 402
Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience J. MathewA. AgrawalJ. F. R. Robertson Report 02 March 2008 Pages: 403 - 407
Pooled analysis of diarrhea events in patients with cancer treated with lapatinib John P. CrownHarold A. Burris IIISteve Chan Erratum 15 March 2008 Pages: 409 - 410